ADD-ASPIRIN trial: Principal Investigator for Oesophago-Gastric cohort

Turkington, R. (Chair)

School of Medicine, Dentistry and Biomedical Sciences
The Johnston Cancer Research Centre

Activity: Other activity types › Other

Description

A phase III, double-blind, placebo-controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours

Period	25 Oct 2017 → 21 Feb 2025
Held at	University College London, United Kingdom
Degree of Recognition	International

ADD-ASPIRIN trial: Principal Investigator for Oesophago-Gastric cohort

Description

Related content

Research output

High PTGS2 expression in post neoadjuvant chemotherapy treated oesophageal adenocarcinoma is associated with improved survival: a population-based cohort study